Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217546 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Richard T Waldron und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Electronic address: Richard.waldron@cshs.org. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Cell-Derived Microparticles, Carcinoma, Pancreatic Ductal, Neoplastic Cells, Circulating. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIDDK NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Metastatic pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with limited efficacious therapeutic options. Recent investigations have provided proof of concept that circulating tumor cells (CTCs) are reduced by purification of PDAC patient blood samples through ExThera Seraph100™ adsorption filters. Whether additional tumorigenic factors are also removed remains inadequately studied. Here, matched whole blood and purified blood samples from seven PDAC patients were analyzed for microparticle and soluble protein content. For microparticle analysis, patient samples were stratified by abundance. Filters markedly reduced ∼200-nm particles when in high abundance. Exosomes, or vesicles ranging from ∼50 to 150-nm were not significantly affected by the purification process. Proteomic analysis of plasma from the whole and purified blood revealed only a limited number of differentially expressed proteins. The complement C1Q proteins were reduced by the purification process, likely due to their heparin binding affinity. In contrast, there was an elevation in cytoplasmic proteins after purification, which may be due to cell destruction. Taken together, this study shows the selective removal of a subfraction of larger (>200 nm) microvesicles and C1Q during blood purification by the Seraph100™. The clinical significance of these findings requires further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. Electronic address: Richard.waldron@cshs.org.
- Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
- Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, 90089, USA.
- Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
- Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, 90089, USA; Institute of Urology, Catherine & Joseph Aresty Department of Urology, Keck School of Medicine,…
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Waldron, R. T., Wang, R., Shishido, S. N., Lugea, A., Ibrahim, A. G., Mason, J., Ayres, M., Parker, S. J., Van Eyk, J. E., Lo, S. K., Kuhn, P., & Pandol, S. J. (2025). Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217546
Vancouver
Waldron RT, Wang R, Shishido SN, Lugea A, Ibrahim AG, Mason J, et al. Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217546
BibTeX
@article{Waldron2025,
author = {Waldron, Richard T and Wang, Ruoxiang and Shishido, Stephanie N and Lugea, Aurelia and Ibrahim, Ahmed G and Mason, Jeremy and Ayres, Matthew and Parker, Sarah J and Van Eyk, Jennifer E and Lo, Simon K and Kuhn, Peter and Pandol, Stephen J},
title = {Selective removal of proteins and microvesicles ex vivo from blood of pancreatic cancer patients using bioengineered adsorption filters},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217546}
}
EUVIMED